文献速递术前评估与围术期医学

体外研究:罗库溴铵比琥珀胆碱更具肝细胞毒性

Rocuronium is more hepatotoxic than succinylcholine in vitro.
PubMed 文献 · Eur J Anaesthesiol · 2017-01-01

该体外研究使用人肝癌细胞系HepG2/C3A,比较罗库溴铵与琥珀胆碱的肝毒性。罗库溴铵而非琥珀胆碱导致细胞活力、白蛋白合成和细胞色素1A2活性呈剂量依赖性显著下降,提示罗库溴铵具有剂量依赖性肝毒性,需进一步研究其机制。

要点

  • 罗库溴铵呈剂量依赖性降低HepG2/C3A细胞活力。
  • 罗库溴铵抑制白蛋白合成和细胞色素1A2活性。
  • 琥珀胆碱在相同实验中未显示显著肝毒性。

核心结论

  • 体外细胞系实验显示罗库溴铵具有剂量依赖性肝毒性,而琥珀胆碱未显示。
  • 需进一步研究罗库溴铵影响肝细胞完整性的机制。

研究设计与样本

  • 体外研究,使用人永久性肝细胞系HepG2/C3A进行标准化微孔板毒性测定。
  • 比较不同浓度罗库溴铵、琥珀胆碱与血浆对照的毒性。

主要发现

  • 罗库溴铵而非琥珀胆碱导致细胞活力、白蛋白合成和细胞色素1A2活性呈显著剂量依赖性下降。
  • 经过两个3天孵育期后,通过XTT试验、乳酸脱氢酶释放和台盼蓝染色评估细胞活力。

关键数值与推荐

  • 采用Kruskal-Wallis单因素检验和双尾Mann-Whitney U检验评估罗库溴铵与琥珀胆碱的差异。

临床怎么用

  • 体外结果提示罗库溴铵可能具有肝细胞毒性,临床使用时应关注肝功能,尤其对肝功能障碍患者。
  • 需结合临床研究进一步验证罗库溴铵对肝脏的安全性。

局限性

  • 研究为体外细胞系实验,结果不能直接等同于人体内肝毒性。
  • 未探讨罗库溴铵肝毒性的具体机制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The development of liver failure is a major problem in critically ill patients. The hepatotoxicity of many drugs, as one important reason for liver failure, is poorly screened for in human models. Rocuronium and succinylcholine are neuromuscular blocking agents used for tracheal intubation and for rapid-sequence induction. OBJECTIVE: We used an in-vitro test with a permanent cell line and compared rocuronium and succinylcholine for hepatotoxicity. DESIGN: In-vitro study. SETTING: A basic science laboratory, University Hospital Rostock, Germany. MATERIAL/(PATIENTS): The basic test compound is the permanent human liver cell line HepG2/C3A. In a standardised microtitre plate assay the toxicity of different concentrations of rocuronium, succinylcholine and plasma control was tested. INTERVENTIONS: After two incubation periods of 3 days, the viability of cells (XTT test, lactate dehydrogenase release and trypan blue staining), micro-albumin synthesis and the cytochrome 1A2 activity (metabolism of ethoxyresorufin) were measured. MAIN OUTCOME MEASURES: Differences between rocuronium and succinylcholine were assessed using the Kruskal-Wallis one-way test and two-tailed Mann-Whitney U test. RESULTS: Rocuronium, but not succinylcholine, led to a significant dose-dependent decrease of viability, albumin synthesis and cytochrome 1A2 activity of test cells. CONCLUSION: An in-vitro test with a cell line showed hepatotoxicity of rocuronium that was dose-dependent. Further studies are needed to investigate the underlying mechanisms of the effects of rocuronium on hepatic cellular integrity. TRIAL REGISTRATION: Not suitable.

来源:Eur J Anaesthesiol,查看原文。版权归原作者所有。

引用

  1. Sauer M, Piel I, Haubner C, et al. Rocuronium is more hepatotoxic than succinylcholine in vitro. Eur J Anaesthesiol. 2017. PMID: 28763317. doi:10.1097/EJA.0000000000000666

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。